Publication | Closed Access
Significant Variation in Serotype‐Specific Immunogenicity of the Seven‐Valent<i>Streptococcus pneumoniae</i>Capsular Polysaccharide–CRM<sub>197</sub>Conjugate Vaccine Occurs Despite Vigorous T Cell Help Induced by the Carrier Protein
72
Citations
29
References
2003
Year
ImmunologyImmunodominanceSignificant VariationCd4 T Cell ResponsesImmune SystemConjugate VaccinesSerotype‐specific ImmunogenicityPs ComponentVaccine TargetInfection ControlImmunological MemoryVaccinologyVaccine DevelopmentAutoimmune DiseaseMedicineVaccine ComponentsAutoimmunityT Cell ImmunityHumoral ImmunityPolyvalent VaccineVaccinationCarrier ProteinVaccine DesignPrecision VaccinologyVaccine ResearchViral Immunity
Streptococcus pneumoniae capsular polysaccharides (PnPSs) induce protective antibodies but are T cell-independent type 2 antigens and are poorly immunogenic in infants. Conjugate vaccines of PnPSs linked to proteins like cross-reactive material (CRM(197)) increase PS antibody titer and elicit immunologic memory in infants. Despite being linked to an identical carrier protein, each PS component of the 7-valent PnPS-CRM(197) vaccine has different immunogenicity. To determine whether variations in conjugate-induced memory T cell responses or PnPS-specific antibody-secreting cells (ASCs) were responsible for serotype-specific differences in immunogenicity, adults were immunized with 7-valent PnPS-CRM(197), and antibody titer, vaccine component-specific CD4(+) T cell recall response, numbers of PnPS-specific ASCs, and cytokine production were measured. PnPS-CRM(197) induced significantly different serotype-specific antibody titers, despite vigorous T cell recall responses to all 7 vaccine components, and production of interleukin (IL)-2, IL-5, IL-6, IL-10, and interferon-gamma. We conclude that PnPS-CRM(197) induces variable serotype-specific antibody titers, despite induction of comparable CRM(197)-specific memory T cell responses.
| Year | Citations | |
|---|---|---|
Page 1
Page 1